| Name | Title | Contact Details |
|---|
Sanbor Medical is a Allentown, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
ilumed is a company that helps providers, payers, and other healthcare organizations transition to value-based care models, which focus on quality of health outcomes rather than quantity of services.
Lightning Step is the only all-in-one enterprise software for behavioral health and addiction treatment centers created by treatment professionals. The solution brings together the fundamentals required to operate and grow a successful facility in today`s world, integrating CRM, EMR, and RCM systems and removing the cross-communication pain points of using multiple platforms. Enjoy a smoother operation with one system, one login, one price.
Ampio is an innovative drug discovery and development company combining scientific, regulatory, and business capabilities to efficiently develop a robust portfolio of novel therapeutic candidates. These therapeutic candidates, if approved, will address significant inflammatory conditions for which limited treatment options exist. Ampio’s therapeutic product pipeline has been developed through more than two decades of study at leading hospital-based research centers. Rigorous preclinical and clinical research efforts have yielded a diverse portfolio of late-stage product candidates focusing on the world’s most prevalent inflammatory conditions including osteoarthritis and diabetic macular edema. Significant discoveries in both basic science and clinical research have resulted in Ampio receiving over 180 patents throughout the world, with hundreds more pending. Further, hundreds of peer-reviewed publications, abstracts, and scientific presentations highlight the depth of research supporting Ampio’s therapeutic product candidates. Ampio’s leading product candidates are Ampion™ and Optina™. The company is currently conducting the second pivotal clinical trial in the US for Ampion, a biologic intra-articular injection being studied for the treatment of osteoarthritis of the knee. Ampio is also conducting a late-stage US clinical trial for Optina, an oral agent being studied for the treatment of diabetic macular edema. Millions of patients worldwide are affected by these conditions, for which limited treatment options exist. At Ampio, we strive to offer compelling therapeutic options for the patients most in need of new treatments, and we operate every day to advance our products’ development and make these available to patients.
Since 1949, Gracepoint has cared for people like Rachel who needed a combination of intense therapies combined into her school day to thrive, graduate and find a job she loves. At Gracepoint, adults and children and their families have access to 26 board-certified psychiatrists, therapeutic specialists and 26 locations throughout Tampa Bay. Gracepoint`s mission is educating, advocating and giving hope to people touched by behavioral health and developmental challenges.